You are here

Our science / Clinical Trials / Find a Trial / NCT00356421

A Clinical Trial Comparing Efficacy and Safety of Exubera® and Humalog®

Back to Search Print Save as PDF Bookmark Trial

NCT00356421

Last updated on February 22, 2019
Back to Search Print Save as PDF Bookmark Trial

FOR MORE INFORMATION
Study Location
Pfizer Investigational Site
Hamilton, New Jersey, 08610 United States
See other locations
Contact
1-800-718-1021
[email protected]
Related Links
Eligibility criteria
Condition
The disease, disorder, syndrome, illness, or injury that is being studied.
Type 1 Diabetes Mellitus
Sex
Females and Males
Age
Pediatric Trials: 0-17 Years
Adult Trials: 18+ Years
18 + years
Inclusion criteria
The factors, or reasons, that allow a person to participate in a clinical study.
Show details

- Diabetes mellitus Type 1

Exclusion criteria
The factors, or reasons, that prevent a person from participating in a clinical study.
Show details

- Severe Asthma, severe Chronic Obstructive Pulmonary Disease (COPD)

- Smoking

NCT00356421
Pfizer
Terminated
A Clinical Trial Comparing Efficacy and Safety of Exubera® and Humalog®

NEED INFO?

Questions about a trial? Call or email to reach a Pfizer Clinical Trial Contact Center

Pfizer Clinical Trials Contact Center

1-800-718-1021

[email protected]

call now

Try a new search

Search for Clinical Trials by condition, keyword or trial number. Share your location or enter your city or zip code to find studies near you.
Advanced Search

Based on your search, you may also be interested in

Type 1 Diabetes Mellitus
A Clinical Trial Comparing Efficacy and Safety of Exubera® and Humalog®
NCT00356421
All Genders
18+
Years
Multiple Sites
Type 1 Diabetes Mellitus
Safety And Efficacy Of Exubera Compared With Subcutaneous Human Insulin Therapy In Children And Adolescents
NCT00479258
All Genders
6+
Years
Buffalo, New York
Type 1 Diabetes Mellitus
Six Month Clinical Trial Assessing Efficacy And Safety Of Inhaled Insulin In Type 1 Diabetes Mellitus.
NCT00424437
All Genders
12+
Years
Multiple Sites
Type 1 Diabetes Mellitus
To Examine the Lung When People With Diabetes Take an Inhaled Form of Insulin, Compared to Subcutaneous Insulin.
NCT00143104
All Genders
18+
Years
Multiple Sites

FOR MORE INFORMATION

Contact a representative by phone, email, or visiting the study website. Please see the references below:

BY PHONE

Pfizer Clinical Trials Contact Center

1-800-718-1021

BY EMAIL

Contact

[email protected]

Call Now